... . Aside from the widely known dizziness, nausea and vomiting side effects, gabapentin can also cause peripheral edema. What is peripheral edema? It is a condition that causes the hands and feet to swell. Swelling may take weeks to subside as soon as the initial gabapentin treatment is administered. It may also become painful and bearable for some people. It is strongly advised that ...

Here's something any perpetrator should catch hell for: changing the primary outcome of a trial.* In studies of gabapentin (funded by Parke-Davis and later by Pfizer) for neuropathic pain, bipolar disorder, or migraine prevention (all off-label uses), the protocol-defined primary outcome was often...

... -sponsored reports of randomised trials of off-label use of gabapentin. For eight of the twelve reported trials, the primary outcome ... be stated. This study examined clinical trials of gabapentin for off-label use for migraine prophylaxis, bipolar disorders, ... Pfizer and Parke-Davis relating to off-label use of gabapentin. What does this study claim? The study found that in eight out of twelve ...

Fibromyalgia has a range of symptoms, from pain to fatigue to difficulty sleeping, among others. This wide variety in how it presents can make fibromyalgia a difficult-to-treat illness as there is no treatment for the illness itself, only the signs and symptoms. In addition, there are other problems that are not uncommon among people with fibromyalgia, including irritable bowel disorder and ...

so, here we are. 23 hours after starting this medication, i think the cure may be worse than the affliction. y'see, i hate being out of control. in any situation, i hate being out of control. i really hate it when my body does things i can't direct. this is why i started this journey in the first place-- i found it extremely unpleasant to have a face that assumed a life of its own. ...

... sponsored by Parke-Davis (later merged into Pfizer Inc) of gabapentin (Neurontin) for a variety of clinical problems other than seizures.& ... outcome variables occurred when these comparisons were not favorable to gabapentin. As the authors summarized: Thus, trials with findings that were not statistically ... Outcome reporting in industry-sponsored tirals of gabapentin for off-label use. N Engl J Med ...